{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T19:16:24Z","timestamp":1794078984943,"version":"4.8.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T00:00:00Z","timestamp":1550620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wyck Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00415-019-09228-w","type":"journal-article","created":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T14:29:14Z","timestamp":1550672954000},"page":"998-1006","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Disease burden of myotonic dystrophy type 1"],"prefix":"10.1007","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5758-7151","authenticated-orcid":false,"given":"Erik","family":"Landfeldt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoletta","family":"Nikolenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Jimenez-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cumming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren G.","family":"Monckton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grainne","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns","family":"Lochm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,20]]},"reference":[{"key":"9228_CR1","volume-title":"Myotonic dystrophy","author":"PS Harper","year":"2001","unstructured":"Harper PS (2001) Myotonic dystrophy, 3rd\u00a0edn. W.B. Saunders, London","edition":"3"},{"issue":"2","key":"9228_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.nmd.2016.12.005","volume":"27","author":"C Lindberg","year":"2017","unstructured":"Lindberg C, Bjerkne F (2017) Prevalence of myotonic dystrophy type 1 in adults in western Sweden. Neuromuscul Disord 27(2):159\u2013162","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"9228_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3233\/JND-180329","volume":"5","author":"C Gagnon","year":"2018","unstructured":"Gagnon C, Heatwole C, H\u00e9bert LJ et al. (2018) Report of the third outcome measures in myotonic dystrophy type 1 (OMMYD-3) international workshop Paris, France, June 8, 2015. J Neuromuscul Dis 5(4):523\u2013537","journal-title":"J Neuromuscul Dis"},{"issue":"13","key":"9228_CR4","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1212\/01.wnl.0000257819.47628.41","volume":"68","author":"KA Vincent","year":"2007","unstructured":"Vincent KA, Carr AJ, Walburn J et al (2007) Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL). Neurology 68(13):1051\u20131057","journal-title":"Neurology"},{"key":"9228_CR5","first-page":"61","volume":"277","author":"M Gomes-Pereira","year":"2004","unstructured":"Gomes-Pereira M, Bidichandani SI, Monckton DG (2004) Analysis of unstable triplet repeats using small-pool polymerase chain reaction. Methods Mol Biol 277:61\u201376","journal-title":"Methods Mol Biol"},{"issue":"1","key":"9228_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hmg\/4.1.1","volume":"4","author":"DG Monckton","year":"1995","unstructured":"Monckton DG, Wong L-JC, Ashizawa T, Caskey CT (1995) Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: small pool PCR analyses. Hum Mol Genet 4(1):1\u20138","journal-title":"Hum Mol Genet"},{"key":"9228_CR7","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1093\/hmg\/dds185","volume":"21","author":"F Morales","year":"2012","unstructured":"Morales F, Couto JM, Higham CF et al (2012) Somatic instability of the expanded CTG triplet repeat in myotonic dystrophy type 1 is a heritable quantitative trait and modifier of disease severity. Hum Mol Genet 21:3558\u20133567","journal-title":"Hum Mol Genet"},{"issue":"1","key":"9228_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13023-016-0417-z","volume":"11","author":"S Baldanzi","year":"2016","unstructured":"Baldanzi S, Bevilacqua F, Lorio R, Volpi L, Simoncini C, Petrucci A et al. (2016) Disease awareness in myotonic dystrophy type 1: An observational cross-sectional study. Orphanet J Rare Dis 11(1):34","journal-title":"Orphanet J Rare Dis"},{"issue":"2\u20133","key":"9228_CR9","first-page":"126","volume":"34","author":"M Peric","year":"2015","unstructured":"Peric M, Peric S, Rapajic N, Dobricic V, Savic-Pavicevic D, Nesic I et al. (2015) Multidimensional aspects of pain in myotonic dystrophies. Acta Myol 34(2\u20133):126\u2013132","journal-title":"Acta Myol"},{"key":"9228_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.clineuro.2014.08.021","volume":"126","author":"V Rakocevic-Stojanovic","year":"2014","unstructured":"Rakocevic-Stojanovic V, Peric S, Madzarevic R, Dobricic V, Ralic V, Ilic V et al (2014) Significant impact of behavioral and cognitive impairment on quality of life in patients with myotonic dystrophy type 1. Clin Neurol Neurosurg 126:76\u201381","journal-title":"Clin Neurol Neurosurg"},{"key":"9228_CR11","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1212\/WNL.0b013e318260cbe6","volume":"79","author":"C Heatwole","year":"2012","unstructured":"Heatwole C, Bode R, Johnson N et al (2012) Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Neurology 79:348\u2013357","journal-title":"Neurology"},{"issue":"6","key":"9228_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.nmd.2009.03.007","volume":"19","author":"L Laberge","year":"2009","unstructured":"Laberge L, Dauvilliers Y, Begin P, Richer L, Jean S, Mathieu J (2009) Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: to lump or split? Neuromuscul Disord 19(6):397\u2013402","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"9228_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/16501970500477967","volume":"38","author":"G Antonini","year":"2006","unstructured":"Antonini G, Soscia F, Giubilei F, De Carolis A, Gragnani F, Morino S et al (2006) Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning. J Rehabil Med 38(3):181\u2013185","journal-title":"J Rehabil Med"},{"issue":"6","key":"9228_CR14","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/S0873-2159(15)31251-4","volume":"16","author":"T Lucena Ara\u00fajo","year":"2010","unstructured":"Lucena Ara\u00fajo T, Regiane Resqueti V, Bruno S, Guerra Azevedo I, Dourado J\u00fanior ME, Fregonezi G (2010) Respiratory muscle strength and quality of life in myotonic dystrophy patients. Revista Portuguesa de Pneumologia 16(6):892\u2013898","journal-title":"Revista Portuguesa de Pneumologia"},{"issue":"3","key":"9228_CR15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.clineuro.2012.05.015","volume":"115","author":"S Peric","year":"2013","unstructured":"Peric S, Stojanovic VR, Basta I, Peric M, Milicev M, Pavlovic S et al (2013) Influence of multisystemic affection on health-related quality of life in patients with myotonic dystrophy type 1. Clin Neurol Neurosurg 115(3):270\u2013275","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"9228_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10897-014-9752-1","volume":"24","author":"A Geirdal","year":"2015","unstructured":"Geirdal A, Lund-Petersen I, Heiberg A (2015) Understanding the experience of myotonic dystrophy. Mixed method study. J Genetic Couns 24(1):169\u2013178","journal-title":"J Genetic Couns"},{"issue":"6","key":"9228_CR17","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/ane.12788","volume":"136","author":"S Peric","year":"2017","unstructured":"Peric S, Heatwole C, Durovic E, Kacar A, Nikolic A, Basta I et al (2017) Prospective measurement of quality of life in myotonic dystrophy type 1. Acta Neurol Scand 136(6):694\u2013697","journal-title":"Acta Neurol Scand"},{"key":"9228_CR18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1745-3992.1997.tb00606.x","volume":"52","author":"B Wright","year":"1997","unstructured":"Wright B (1997) A history of social science and measurement. Educ Meas 52:33\u201352","journal-title":"Educ Meas"},{"issue":"12","key":"9228_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta13120","volume":"13","author":"J Hobart","year":"2009","unstructured":"Hobart J, Cano S (2009) Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods. Health Technol Assess 13(12):1\u2013177","journal-title":"Health Technol Assess"},{"issue":"8","key":"9228_CR20","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1474-4422(18)30203-5","volume":"17","author":"K Okkersen","year":"2018","unstructured":"Okkersen K, Jimenez-Moreno C, Wenninger S, Daidj F, Glennon J, Cumming S et al (2018) Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial. Lancet Neurol 17(8):671\u2013680","journal-title":"Lancet Neurol"},{"key":"9228_CR21","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3389\/fneur.2018.00780","volume":"9","author":"MJ Hamilton","year":"2018","unstructured":"Hamilton MJ, McLean J, Cumming S et al (2018) Outcome measures for central nervous system evaluation in myotonic dystrophy type 1 may be confounded by deficits in motor function or insight. Front Neurol 9:780","journal-title":"Front Neurol"},{"issue":"2","key":"9228_CR22","doi-asserted-by":"publisher","first-page":"e0148264","DOI":"10.1371\/journal.pone.0148264","volume":"11","author":"C Dogan","year":"2016","unstructured":"Dogan C, De Antonio M, Hamroun D et al (2016) Gender as a modifying factor influencing myotonic dystrophy type 1 phenotype severity and mortality: a nationwide multiple databases cross-sectional observational study. PLoS One 11(2):e0148264. https:\/\/doi.org\/10.1371\/journal.pone.0148264","journal-title":"PLoS One"},{"key":"9228_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.msard.2018.07.002","volume":"24","author":"E Landfeldt","year":"2018","unstructured":"Landfeldt E, Castelo-Branco A, Svedbom A et al (2018) The long-term impact of multiple sclerosis on the risk of divorce. Mult Scler Relat Disord 24:145\u2013150","journal-title":"Mult Scler Relat Disord"},{"key":"9228_CR24","first-page":"1164","volume":"52","author":"HG Harley","year":"1993","unstructured":"Harley HG, Rundle SA, MacMillan JC et al (1993) Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet 52:1164\u20131174","journal-title":"Am J Hum Genet"},{"key":"9228_CR25","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1136\/jmg.29.11.774","volume":"29","author":"A Hunter","year":"1992","unstructured":"Hunter A, Tsilfidis C, Mettler G et al (1992) The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy. J Med Genet 29:774\u2013779","journal-title":"J Med Genet"},{"key":"9228_CR26","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1001\/jama.1993.03500150072029","volume":"269","author":"JB Redman","year":"1993","unstructured":"Redman JB, Fenwick RG, Fu Y-H, Pizzuti A, Caskey CT (1993) Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring. J Am Med Assoc 269:1960\u20131965","journal-title":"J Am Med Assoc"},{"issue":"5","key":"9228_CR27","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/ane.12549","volume":"134","author":"S Peric","year":"2016","unstructured":"Peric S, Vujnic M, Dobricic V, Marjanovic A, Basta I, Novakovic I et al (2016) Five-year study of quality of life in myotonic dystrophy. Acta Neurol Scand 134(5):346\u2013351","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"9228_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta5040","volume":"5","author":"C Eiser","year":"2001","unstructured":"Eiser C, Morse R (2001) Quality-of-life measures in chronic diseases of childhood. Health Technol Assess 5(4):1\u201357","journal-title":"Health Technol Assess"},{"issue":"5","key":"9228_CR29","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/dmcn.12938","volume":"58","author":"E Landfeldt","year":"2016","unstructured":"Landfeldt E, Lindgren P, Bell C et al (2016) Health-related quality of life in patients with duchenne muscular dystrophy: a multi-national, cross-sectional study. Dev Med Child Neurol 58(5):508\u2013515","journal-title":"Dev Med Child Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09228-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09228-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09228-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T23:22:06Z","timestamp":1720999326000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09228-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,20]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["9228"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09228-w","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,20]]},"assertion":[{"value":"4 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study has been supported by the National Institute of Health Research (NIHR) under the RD-TRC programme and by the Wyck Foundation. Dr. Hanns Lochm\u00fcller is an investigator of the Medical Research Council UK Centre for Neuromuscular Diseases (reference G1002274, grant ID 98482). The other authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Study ethical approval was granted by the Newcastle and North Tyneside Ethics Committee (reference: NE\/15\/0178). The study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All patients gave their informed consent prior to their inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}